NovaLead Pharma commences Phase 3 Clinical Trial of Its Novel Topical Drug Galnobax for DFU
Subject to satisfactory completion of Phase 3 trial, Galnobax can be a path-breaking treatment for Diabetic Foot Ulcer (DFU)
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Galnobax
NovaLead Pharma completes global phase I /II clinical trial for Galnobax
Galnobax, a topical gel, will help in the treatment of diabetic foot ulcer NovaLead Pharma announced a potential breakthrough…